Phenotypic Heterogeneity in Patients with NEFL-related Charcot-Marie-Tooth Disease

Overview

Journal Mol Genet Genomic Med

Specialty Genetics

Date 2022 Jan 19

PMID 35044100

Authors

Hye Jin Kim

Sang Beom Kim

Hyun Su Kim

Hye Mi Kwon

Jae Hong Park

Ah Jin Lee

Si On Lim

Soo Hyun Nam

Young Bin Hong

Ki Wha Chung

Byung-Ok Choi

Affiliations

Soon will be listed here.

Abstract

Charcot-Marie-Tooth disease (CMT) is the most common hereditary peripheral neuropathy. Mutations in the neurofilament light polypeptide (NEFL) gene produce diverse clinical phenotypes, including demyelinating (CMT1F), axonal (CMT2E), and intermediate (CMTDIG) neuropathies. From 2005 to 2020, 1,143 Korean CMT families underwent gene sequencing, and we investigated the clinical, genetic, and neuroimaging spectra of NEFL-related CMT patients. Ten NEFL mutations in 17 families (1.49%) were identified, of which three (p.L312P, p.Y443N, and p.K467N) were novel. Eight de novo cases were identified at a rate of 0.47 based on a cosegregation analysis. The age of onset was ≤3 years in five cases (13.5%). The patients revealed additional features including delayed walking, ataxia, dysphagia, dysarthria, dementia, ptosis, waddling gait, tremor, hearing loss, and abnormal visual evoked potential. Signs of ataxia were found in 26 patients (70.3%). In leg MRI analyses, various degrees of intramuscular fat infiltration were found. All compartments were evenly affected in CMT1F patients. The anterior and anterolateral compartments were affected in CMT2E, and the posterior compartment was affected in CMTDIG. Thus, NEFL-related CMT patients showed phenotypic heterogeneities. This study's clinical, genetic, and neuroimaging results could be helpful in the evaluation of novel NEFL variants and differential diagnosis against other CMT subtypes.

Citing Articles

Novel Genetic and Biochemical Insights into the Spectrum of NEFL-Associated Phenotypes.

Marina A, Hentschel A, Czech A, Schara-Schmidt U, Preusse C, Laner A J Neuromuscul Dis. 2024; 11(3):625-645.

PMID: 38578900 PMC: 11091643. DOI: 10.3233/JND-230230.

Neurofilaments in health and Charcot-Marie-Tooth disease.

Kotaich F, Caillol D, Bomont P Front Cell Dev Biol. 2024; 11:1275155.

PMID: 38164457 PMC: 10758125. DOI: 10.3389/fcell.2023.1275155.

The CRL3 ubiquitin ligase-USP15 pathway governs the destruction of neurofilament proteins.

Park H, Le L, Nguyen T, Nam K, Ordureau A, Lee J Proc Natl Acad Sci U S A. 2023; 120(45):e2306395120.

PMID: 37903270 PMC: 10636361. DOI: 10.1073/pnas.2306395120.

The 2022 Lady Estelle Wolfson lectureship on neurofilaments.

Petzold A J Neurochem. 2022; 163(3):179-219.

PMID: 35950263 PMC: 9826399. DOI: 10.1111/jnc.15682.

Phenotypic heterogeneity in patients with NEFL-related Charcot-Marie-Tooth disease.

Kim H, Kim S, Kim H, Kwon H, Park J, Lee A Mol Genet Genomic Med. 2022; 10(2):e1870.

PMID: 35044100 PMC: 8830812. DOI: 10.1002/mgg3.1870.

References

DiVincenzo C, Elzinga C, Medeiros A, Karbassi I, Jones J, Evans M . The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathy. Mol Genet Genomic Med. 2015; 2(6):522-9. PMC: 4303222. DOI: 10.1002/mgg3.106. View

Berciano J, Garcia A, Peeters K, Gallardo E, De Vriendt E, Pelayo-Negro A . NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype. J Neurol. 2015; 262(5):1289-300. DOI: 10.1007/s00415-015-7709-4. View

Yoshimura A, Yuan J, Hashiguchi A, Ando M, Higuchi Y, Nakamura T . Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan. J Neurol Neurosurg Psychiatry. 2018; 90(2):195-202. PMC: 6518473. DOI: 10.1136/jnnp-2018-318839. View

Abe A, Numakura C, Saito K, Koide H, Oka N, Honma A . Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype. J Hum Genet. 2009; 54(2):94-7. DOI: 10.1038/jhg.2008.13. View

Fabrizi G, Cavallaro T, Angiari C, Cabrini I, Taioli F, Malerba G . Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton. Brain. 2006; 130(Pt 2):394-403. DOI: 10.1093/brain/awl284. View

Perez-Olle R, Leung C, Liem R . Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J Cell Sci. 2002; 115(Pt 24):4937-46. DOI: 10.1242/jcs.00148. View

Benedetti S, Previtali S, Coviello S, Scarlato M, Cerri F, Di Pierri E . Analyzing histopathological features of rare charcot-marie-tooth neuropathies to unravel their pathogenesis. Arch Neurol. 2010; 67(12):1498-505. DOI: 10.1001/archneurol.2010.303. View

Previtali S, Zerega B, Sherman D, Brophy P, Dina G, King R . Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve. Hum Mol Genet. 2003; 12(14):1713-23. DOI: 10.1093/hmg/ddg179. View

Paternostro-Sluga T, Grim-Stieger M, Posch M, Schuhfried O, Vacariu G, Mittermaier C . Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med. 2008; 40(8):665-71. DOI: 10.2340/16501977-0235. View

10.

Lee M, Park C, Chung H, Kim H, Choi Y, Yoo J . Cerebral white matter abnormalities in patients with charcot-marie-tooth disease. Ann Neurol. 2016; 81(1):147-151. DOI: 10.1002/ana.24824. View

11.

Yum S, Zhang J, Mo K, Li J, Scherer S . A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy. Ann Neurol. 2009; 66(6):759-70. PMC: 4439312. DOI: 10.1002/ana.21728. View

12.

Yuan A, Rao M, Veeranna , Nixon R . Neurofilaments at a glance. J Cell Sci. 2012; 125(Pt 14):3257-63. PMC: 3516374. DOI: 10.1242/jcs.104729. View

13.

Adebola A, Di Castri T, He C, Salvatierra L, Zhao J, Brown K . Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype. Hum Mol Genet. 2015; 24(8):2163-74. PMC: 4380066. DOI: 10.1093/hmg/ddu736. View

14.

Shin J, Chung K, Cho S, Yun J, Hwang S, Kang S . NEFL Pro22Arg mutation in Charcot-Marie-Tooth disease type 1. J Hum Genet. 2008; 53(10):936-940. DOI: 10.1007/s10038-008-0333-8. View

15.

Jordanova A, De Jonghe P, Boerkoel C, Takashima H, De Vriendt E, Ceuterick C . Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain. 2003; 126(Pt 3):590-7. DOI: 10.1093/brain/awg059. View

16.

Gess B, Schirmacher A, Boentert M, Young P . Charcot-Marie-Tooth disease: frequency of genetic subtypes in a German neuromuscular center population. Neuromuscul Disord. 2013; 23(8):647-51. DOI: 10.1016/j.nmd.2013.05.005. View

17.

Sadjadi R, Reilly M, Shy M, Pareyson D, Laura M, Murphy S . Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis. J Peripher Nerv Syst. 2014; 19(3):192-6. PMC: 4303498. DOI: 10.1111/jns.12084. View

18.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

19.

Manganelli F, Tozza S, Pisciotta C, Bellone E, Iodice R, Nolano M . Charcot-Marie-Tooth disease: frequency of genetic subtypes in a Southern Italy population. J Peripher Nerv Syst. 2014; 19(4):292-8. DOI: 10.1111/jns.12092. View

20.

Choi B, Lee M, Shin S, Hee Hwang J, Choi K, Kim W . Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients. Hum Mutat. 2004; 24(2):185-6. DOI: 10.1002/humu.9261. View